Pfizer 2008 Annual Report Download - page 67

Download and view the complete annual report

Please find page 67 of the 2008 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 100

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100

Notes to Consolidated Financial Statements
Pfizer Inc and Subsidiary Companies
The contractual maturities of the available-for-sale and held-to-maturity debt securities as of December 31, 2008, follow:
YEARS
(MILLIONS OF DOLLARS) WITHIN 1
OVER 1
TO 5
OVER 5
TO 10
OVER
10 TOTAL
Available-for-sale debt securities:
Western European and other government debt $12,729 $1,821 $89 $— $14,639
Corporate debt 2,414 2,974 — — 5,388
Western European and other government agency debt 4,032 1,008 — — 5,040
Federal Home Loan Mortgage Corporation, Federal National Mortgage
Association and Government National Mortgage Association asset-
backed securities — 2,386 — — 2,386
Supranational debt 1,328 628 — — 1,956
Other asset-backed securities 336 299 — — 635
Certificates of deposit 17 — — — 17
Held-to-maturity debt securities:
Certificates of deposit and other 2,335 4 5 5 2,349
Total debt securities $23,191 $9,120 $94 $ 5 $32,410
Trading investments 190
Available-for-sale money market funds 398
Available-for-sale equity securities, excluding money market funds 319
Total investments $33,317
B. Short-Term Borrowings
Short-term borrowings include amounts for commercial paper of $7.8 billion as of December 31, 2008, and $4.4 billion as of
December 31, 2007. The weighted-average effective interest rate on short-term borrowings outstanding was 1.9% as of
December 31, 2008, and 3.4% as of December 31, 2007.
As of December 31, 2008, we had access to $7.2 billion of lines of credit, of which $5.1 billion expire within one year. Of these lines
of credit, $7.1 billion are unused, of which our lenders have committed to loan us $6.1 billion at our request. $6.0 billion of the
unused lines of credit, of which $4.0 billion expire in 2009 and $2.0 billion expire in 2013, may be used to support our commercial
paper borrowings.
C. Long-Term Debt
Information about our long-term debt as of December 31 follows:
(MILLIONS OF DOLLARS) MATURITY DATE 2008 2007
Senior unsecured notes:
4.55% euro May 2017 $1,312 $1,291
4.75% euro December 2014 1,311 1,296
6.60% December 2028 1,015 764
4.50% February 2014 836 753
1.21% Japanese yen February 2011 662 530
1.30% Japanese yen November 2011 662 —
6.50% December 2018 624 527
1.85% Japanese yen February 2016 606 484
4.65% March 2018 357 300
6.75% December 2027 309 233
5.63% April 2009 —612
3.30% March 2009 —297
Other:
Debentures, notes, borrowings and mortgages 269 227
Total long-term debt $7,963 $7,314
Current portion not included above $ 937 $1,024
Long-term debt outstanding as of December 31, 2008, matures in the following years:
(MILLIONS OF DOLLARS) 2010 2011 2012 2013
AFTER
2013
Maturities $37 $1,348 $19 $8 $6,551
2008 Financial Report 65